Saturday, November 21, 2026
News

Cipla receives EUA for oral antiviral drug to treat mild to moderate Covid

SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | Tuesday, 2021 7:15:08 PM IST
Cipla Limited announced on Tuesday that it has been granted Emergency Use Authorization (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir, an anti-viral drug to treat mild to moderate Covid-19.

Cipla plans to launch Molnupiravir under the brand name Cipmolnu. Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate Covid-19 at high risk of developing severe disease.

Earlier this year, Cipla entered into a non-exclusive voluntary licensing agreement with Merck Sharpe Dohme (MSD) to manufacture and supply Molnupiravir in India and to over 100 low and middle-income countries (LMICs). The regulatory approval comes on the back of a five-month collaborative trial conducted by a consortium of companies.

Cipla will soon make Cipmolnu 200mg capsules which will be available at all leading pharmacies and Covid treatment centres across the country.

The company has adequate manufacturing capacities and a solid distribution mechanism in place to ensure speedy access to this effective treatment pan India.

Molnupiravir is an oral anti-viral that inhibits the replication of multiple RNA viruses including SARS-CoV-2. The drug is used for the treatment of non-hospitalised patients with Covid-19 globally.

Commenting on the launch, Umang Vohra (MD and Global CEO, Cipla Limited) said it was "yet another step in our endeavour to enable access to all treatments in Covid care".

--IANS san/ksk/

( 252 Words)

2021-12-28-13:22:04 (IANS)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Fire breaks out in Delhi's Karol Bagh, n...
Five Commissionerates will ensure better...
People do not want CPI(M) back in power...
Gujarat Dy CM Harsh Sanghavi attends con...
Domestic help murder case: Accused denti...
'India and Oman are natural maritime par...
More...    
 
 Top Stories
Harry Kane suffers torn ankle ligam... 
‘If you target Americans, justice w... 
1st Test: Rahul, Padikkal steer Ind... 
“People do not want CPI(M) back in ... 
“Iran’s tyrannical regime puts its ... 
“Not every agreement is worth accep... 
India-US maritime cooperation grows... 
"We’ve achieved nothing yet": Babar...